发明名称 |
METHODS FOR TREATING AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA ASSOCIATED WITH PCSK9 GAIN-OF-FUNCTION MUTATIONS |
摘要 |
<p>The present invention provides methods for treating autosomal dominant hypercholesterolemia (ADH). According to certain embodiments, the ADH is caused by or associated with a gain-of- function mutation (GOFm) in a gene encoding PCSK9. The present invention therefore includes methods comprising selecting a patient who carries a GOFm in one or both alleles of the PCSK9 gene, and administering to the patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody such as the exemplary antibody referred to herein as mAb316P.</p> |
申请公布号 |
WO2014194111(A1) |
申请公布日期 |
2014.12.04 |
申请号 |
WO2014US40050 |
申请日期 |
2014.05.29 |
申请人 |
REGENERON PHARMACEUTICALS, INC. |
发明人 |
SWERGOLD, GARY;MELLIS, SCOTT;SASIELA, WILLIAM, J. |
分类号 |
C07K16/40;A61K39/00;C12Q1/68 |
主分类号 |
C07K16/40 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|